SCHEMBL27735445

SCHEMBL27735445

CC(C)(C)C(=O)ON1CCC(Nc2ncc(C#N)c(N)n2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 1/20 0.44
▸ CDK1 P06493 15/20 0.42
▸ CDK2 P24941 15/20 0.42
▸ CDK4 P11802 14/20 0.42
▸ CCND1 P24385 14/20 0.42
▸ CCNT1 O60563 1/20 0.42
▸ CCNB1 P14635 1/20 0.42
▸ CCNE1 P24864 1/20 0.42
▸ CCND3 P30281 1/20 0.42
▸ CDK7 P50613 1/20 0.42
▸ CDK9 P50750 1/20 0.42
▸ CCNH P51946 1/20 0.42
▸ MNAT1 P51948 1/20 0.42
▸ CDK6 Q00534 1/20 0.42
▸ CCNK O75909 1/20 0.39
▸ CDK12 Q9NYV4 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ JUN P05412 1/20 0.38
▸ MAPK8 P45983 1/20 0.38
▸ MAPK9 P45984 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3776834 0.84 NSD2 (0.49) IRAK4CDK1CDK2CDK4CCND1
SCHEMBL16671765 0.81 PIK3CD (0.49) IRAK4CDK1CDK2CDK4CCND1
SCHEMBL27708448 0.78 CDK1 (0.69) CDK1CDK2CDK4CCND1CDK7
SCHEMBL31524129 0.78 NPC1 (0.51) IRAK4CDK1CDK2CDK4CCND1
SCHEMBL27818542 0.76 IRAK4 (0.45) IRAK4CDK1CDK2CDK4CCND1
SCHEMBL27756075 0.76 CDK12 (0.43) CCNKCDK12MAPK8MAPK9
SCHEMBL1936977 0.75 IRAK4 (0.46) IRAK4CDK1CDK2CDK4CCND1
SCHEMBL1936981 0.75 IRAK4 (0.46) IRAK4CDK1CDK2CDK4CCND1
SCHEMBL27818541 0.75 IRAK4 (0.46) IRAK4CDK1CDK2CDK4CCND1
SCHEMBL28171801 0.75 KDM4E (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101405284-A Pyrimidine, quinazoline, pteridine and derivatives HOFFMANN LA ROCHE (CH) 2009-04-08 — — CN disclosed
Send feedback